HPV Vaccine Delays Persist in Teens
Missed opportunities for HPV vaccination before sexual debut remain common, with practice variation and timing influencing uptake
-
By
-
Conexiant News Staff
-
March 18, 2026
-
Clinical Scorecard: HPV Vaccine Delays Persist in Teens
At a Glance
| Category | Detail |
|---|
| Condition | Human Papillomavirus (HPV) Vaccination |
| Key Mechanisms | Vaccination prior to sexual debut maximizes effectiveness in preventing HPV-related cancers. |
| Target Population | Adolescents aged 13 to 18 years |
| Care Setting | Pediatric primary care network |
Key Highlights
- 79% of adolescents completed the vaccination series prior to sexual debut.
- 12% of adolescents remained unvaccinated prior to sexual activity.
- Missed opportunities were higher among non-Hispanic White and commercially insured patients.
- Clinics initiating HPV vaccination at age 9 had lower missed opportunity rates.
- Findings suggest missed opportunities may relate to physician practices and clinic processes.
Guideline-Based Recommendations
Diagnosis
- Assess vaccination status during primary care visits.
Management
- Encourage HPV vaccination initiation at age 9 to reduce missed opportunities.
Monitoring & Follow-up
- Track vaccination completion rates and follow up with unvaccinated patients.
Risks
- Increased risk of HPV-related cancers due to delayed vaccination.
Patient & Prescribing Data
Adolescents aged 13 to 18 years attending primary care visits.
Early vaccination strategies and improved clinic workflows can enhance vaccine uptake.
Clinical Best Practices
- Implement standardized communication about HPV vaccination.
- Enhance workflow processes to ensure timely vaccination.
- Educate families on the importance of early vaccination.
References
